PipelineReview.com – Biotech News & Online Store – Schering-Plough …

In this large, prospective, randomized , multinational clinical trial , slow responders were randomized at treatment week 36 to receive PEGINTRON combination therapy for a total of 48 weeks (n=86) (standard approved duration) or 72 weeks …. cellulitis); emphysema, bronchiolitis obliterans, pleural effusion, gastroenteritis, pancreatitis, gout , hyperglycemia, hyperthyroidism and hypothyroidism, autoimmune thrombocytopenia with or without purpura, rheumatoid arthritis , ..

See the rest here: 
PipelineReview.com – Biotech News & Online Store – Schering-Plough …

No comments yet.

TOP